Page last updated: 2024-10-28

ethidium and Vascular Diseases

ethidium has been researched along with Vascular Diseases in 1 studies

Ethidium: A trypanocidal agent and possible antiviral agent that is widely used in experimental cell biology and biochemistry. Ethidium has several experimentally useful properties including binding to nucleic acids, noncompetitive inhibition of nicotinic acetylcholine receptors, and fluorescence among others. It is most commonly used as the bromide.
ethidium : The fluorescent compound widely used in experimental cell biology and biochemistry to reveal double-stranded DNA and RNA.

Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Research Excerpts

ExcerptRelevanceReference
"Sulfaphenazole treatment significantly reduced superoxide production in arterial walls following I/R injury."1.33Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction. ( Bai, N; Granville, DJ; Hunter, AL; Laher, I, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hunter, AL1
Bai, N1
Laher, I1
Granville, DJ1

Other Studies

1 other study available for ethidium and Vascular Diseases

ArticleYear
Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction.
    Vascular pharmacology, 2005, Volume: 43, Issue:4

    Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family

2005